{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:12:59Z","timestamp":1790007179743,"version":"4.0.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>COVID-19 vaccines have been approved due to their excellent safety and efficacy data and their use has also permitted to reduce neurological complications of SARS-CoV-2. However, clinical trials were underpowered to detect rare adverse events. Herein, the aim was to characterize the clinical spectrum and immunological features of central nervous system (CNS) immune-related events following SARS-CoV-2 vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multicenter, retrospective, cohort study (December 1, 2020-April 30, 2022). Inclusion criteria were (1) <jats:italic>de novo<\/jats:italic> CNS disorders developing after SARS-CoV-2 vaccination (probable causal relationship as per 2021 Butler criteria) (2); evidence for an immune-mediated etiology, as per (i) 2016 Graus criteria for autoimmune encephalitis (AE); (ii) 2015 Wingerchuk criteria for neuromyelitis optica spectrum disorders; (iii) criteria for myelitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nineteen patients were included from 7 tertiary referral hospitals across Italy and France (one of them being a national referral center for AE), over almost 1 year and half of vaccination campaign. Vaccines administered were mRNA-based (63%) and adenovirus-vectored (37%). The median time between vaccination and symptoms onset was 14 days (range: 2-41 days). CSF was inflammatory in 74%; autoantibodies were detected in 5%. CSF cytokine analysis (n=3) revealed increased CXCL-10 (IP-10), suggesting robust T-cell activation. The patients had AE (58%), myelitis (21%), acute disseminated encephalomyelitis (ADEM) (16%), and brainstem encephalitis (5%). All patients but 2 received immunomodulatory treatment. At last follow-up (median 130 days; range: 32-540), only one patient (5%) had a mRS&amp;gt;2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CNS adverse events of COVID-19 vaccination appear to be very rare even at reference centers and consist mostly of antibody-negative AE, myelitis, and ADEM developing approximately 2 weeks after vaccination. Most patients improve following immunomodulatory treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1344184","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:54:16Z","timestamp":1707148456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study"],"prefix":"10.3389","volume":"15","author":[{"given":"Alberto","family":"Vogrig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dentoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Belluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Verriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bagatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Tocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zoccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Villagr\u00e1n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Davy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-4088-7.00103-6","article-title":"Neurologic complications of vaccinations","volume":"121","author":"Miravalle","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-011-0194-8","article-title":"Guillain-barr\u00e9 syndrome following influenza vaccination: causal or coincidental","volume":"13","author":"Sejvar","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.044","article-title":"Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil","volume":"38","author":"Marchetti","year":"2020","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-326924","article-title":"Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder","volume":"92","author":"Butler","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26339","article-title":"Neurological events reported after COVID-19 vaccines: an analysis of VAERS","volume":"91","author":"Frontera","year":"2022","journal-title":"Ann Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323881","article-title":"Nervous system: subclinical target of SARS-CoV-2 infection","volume":"91","author":"Mariotto","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10050-y","article-title":"Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19","volume":"267","author":"Ameres","year":"2020","journal-title":"J Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11768-1","article-title":"Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis","volume":"270","author":"Abdelhak","year":"2023","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26258","article-title":"Adenovirus COVID-19 vaccines and guillain-barr\u00e9 Syndrome with facial paralysis","volume":"91","author":"Pegat","year":"2022","journal-title":"Ann Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26182","article-title":"Postvaccinal Encephalitis after ChAdOx1 nCov-19","volume":"90","author":"Zuhorn","year":"2021","journal-title":"Ann Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200063","article-title":"Acute inflammatory diseases of the central nervous system after SARS-coV-2 vaccination","volume":"10","author":"Francis","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106839","article-title":"Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination","volume":"208","author":"Vogrig","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06000-3","article-title":"Central nervous system adverse events after ChAdOx1 vaccination","volume":"43","author":"Maramattom","year":"2022","journal-title":"Neurol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11234-4","article-title":"Anti-LGI1 encephalitis following COVID-19 vaccination: a case series","volume":"269","author":"Asioli","year":"2022","journal-title":"J Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.813487","article-title":"Case report: anti-LGI1 encephalitis following COVID-19 vaccination","volume":"12","author":"Zlotnik","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/wnl.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12987-020-0173-2","article-title":"Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient","volume":"17","author":"Castellazzi","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04787-7","article-title":"HLA and immunological features of SARS-CoV-2-induced Guillain-Barr\u00e9 syndrome","volume":"41","author":"Gigli","year":"2020","journal-title":"Neurol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2021","journal-title":"J Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09911-3","article-title":"Guillain-Barr\u00e9 syndrome in the COVID-19 era: just an occasional cluster","volume":"268","author":"Gigli","year":"2021","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11050-w","article-title":"Neuroimmune disorders in COVID-19","volume":"269","author":"Ari\u00f1o","year":"2022","journal-title":"J Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202222","article-title":"CD8+ T cells produce the chemokine CXCL10 in response to CD27\/CD70 costimulation to promote generation of the CD8+ effector T cell pool","volume":"191","author":"Peperzak","year":"2013","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181a6a511","article-title":"Adversomics: the emerging field of vaccine adverse event immunogenetics","volume":"28","author":"Poland","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11194-9","article-title":"MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature","volume":"269","author":"Jarius","year":"2022","journal-title":"J Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103070","article-title":"Molecular mimicry and autoimmunity in the time of COVID-19","volume":"139","author":"Rojas","year":"2023","journal-title":"J Autoimmun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.jaut.2019.06.012","article-title":"Bystander activation and autoimmunity","volume":"103","author":"Pacheco","year":"2019","journal-title":"J Autoimmun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000604","article-title":"Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors","volume":"6","author":"Vogrig","year":"2019","journal-title":"Neurol: Neuroimmunol NeuroInflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200058","article-title":"Anti-hu antibodies in patients with neurologic side effects of immune checkpoint inhibitors","volume":"10","author":"Farina","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030576","article-title":"Encephalitis following COVID-19 vaccination: A systematic review","volume":"11","author":"Abdelhady","year":"2023","journal-title":"Vaccines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(21)00169-0","article-title":"Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis","volume":"2","author":"Parry","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318296e9c3","article-title":"Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer","volume":"80","author":"Honnorat","year":"2013","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420932797","article-title":"Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors","volume":"13","author":"Vogrig","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200129","article-title":"Frequency and referral patterns of neural antibody studies during the COVID-19 pandemic: experience from an autoimmune neurology center","volume":"10","author":"Ari\u00f1o","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e974","DOI":"10.1212\/NXI.0000000000000974","article-title":"Clinical and prognostic value of immunogenetic characteristics in anti-LGI1 encephalitis","volume":"8","author":"Mu\u00f1iz-Castrillo","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030402","article-title":"HLA class II polymorphism and humoral immunity induced by the SARS-coV-2 mRNA-1273 vaccine","volume":"10","author":"Guti\u00e9rrez-Bautista","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jocn.2023.03.008","article-title":"Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review","volume":"111","author":"Nabizadeh","year":"2023","journal-title":"J Clin Neurosci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1344184\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:54:19Z","timestamp":1707148459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1344184\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2024.1344184"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1344184","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"article-number":"1344184"}}